NASDAQ:MCRB - Seres Therapeutics, Inc.
$3.03
 $-0.07
-2.10%
12:10PM EDT
2019-07-22
Seres Therapeutics, Inc., incorporated on October 18, 2010, is a microbiome therapeutics platform company. The Company is engaged in developing a class of biological drugs, which is referred as Ecobiotic microbiome therapeutics. The Company's drugs are designed to restore health by repairing the function of a dysbiotic microbiome. The Company is focused on implementing its microbiome therapeutics platform to develop Ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. SER-109 is its lead product candidate, which is designed to prevent further recurrences of Clostridium difficile infection (CDI). The Company is developing additional product candidates, including SER-262 to prevent an initial recurrence of primary CDI; SER-287 and SER-301, to treat inflammatory bowel disease (IBD), including ulcerative colitis, and SER-155 to treat enteric bacterial pathogens. The Company is also conducting research on metabolic diseases, such as early-stage, non-insulin dependent diabetes; non-alcoholic steatohepatitis, and obesity and metabolic syndrome.As of December 31, 2016, the Company's SER-109, a bacterial spore ecology, consisted of an average of approximately 50 bacterial species derived from healthy donors' fecal matter. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  MCRB     avg for
industry  
  avg for
sector  
42 stocks weight:  14. 97   217. 37   399. 45  
42 stocks rank:  3. 39 K 1. 27 K 716. 99  
# analyst opinions:  7. 00   13. 21   13. 71  
mean recommendation:  2. 00   2. 10   2. 04  

quick ratio:  1. 45   5. 49   1. 88  
current ratio:  1. 63   5. 87   2. 36  

target price low:  4. 00   83. 44   114. 90  
target price avg:  3. 46   106. 20   137. 90  
target price high:  4. 77   132. 30   158. 97  
1-yr high:  9. 20   111. 86   142. 57  
last close:  3. 10   86. 79   125. 44  
50-day avg:  3. 37   86. 68   122. 63  
200-day avg:  5. 73   89. 22   121. 38  
1-yr low:  2. 28   69. 78   100. 51  
volume:  224. 33 K 2. 62 M 3. 43 M
50-day avg volume:  647. 92 K 3. 20 M 4. 16 M
200-day avg volume:  331. 16 K 2. 99 M 4. 75 M

1-day return:  -1. 27 % -1. 30 % -0. 99 %
this week return:  7. 27 % 0. 45 % -0. 20 %
12-wk return:  -57. 82 % 0. 94 % 4. 84 %
52-wk return:  -60. 80 % -1. 30 % 10. 55 %

enterprise value (EV):  97. 27 M 45. 10 B 122. 38 B
market cap:  216. 73 M 38. 96 B 108. 40 B
EBITDA:  -87. 15 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -1. 12   5. 38   11. 93  
enterprise/revenue (EV/R):  3. 08   57. 92   10. 21  
total revenue:  31. 62 M 9. 91 B 39. 98 B
total debt:  23. 47 M 10. 90 B 17. 48 B
net income (common):  -95. 36 M 2. 07 B 4. 05 B

shares outstanding:  41. 09 M 538. 09 M 1. 24 B
shares:  24. 06 M 548. 00 M 1. 22 B
shares short:  4. 33 M 10. 98 M 11. 87 M
shares short prior month:  6. 49 M 9. 32 M 12. 05 M
short ratio:  4. 27   5. 60   3. 34  
short % of float:  39. 33 % 6. 48 % 2. 64 %
total cash/share:  1. 30   10. 98   9. 19  
total cash:  53. 60 M 5. 93 B 6. 10 B
free cash flow:  -45. 67 M 2. 92 B 4. 55 B
operating cash flow:  -68. 48 M 3. 80 B 5. 78 B

book value:  -1. 70   13. 35   27. 45  
price/book:  -1. 82   4. 60   8. 78  
gross profits:  -67. 69 M 7. 44 B 36. 13 B
operating margins:  -300. 72 % -308. 40 % -28. 55 %
EBITDA margins:  -275. 65 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  -201. 68 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -2. 33   2. 10   4. 23  
forward EPS:  -1. 37   3. 45   7. 10  
P/E:  -1. 33   1. 90   32. 10  
forward P/E:  -2. 26   6. 46   15. 47  
PE/G:  -0. 02   0. 70   -0. 54  
growth:  84. 40 % 265. 63 % 79. 11 %
earnings high:  -0. 38   0. 89   1. 68  
earnings avg:  -0. 48   0. 70   1. 57  
earnings low:  -0. 64   0. 46   1. 46  
revenue high:  11. 90 M 2. 57 B 11. 07 B
revenue avg:  8. 13 M 2. 51 B 10. 91 B
revenue low:  3. 90 M 2. 45 B 10. 73 B
return on assets:  -44. 60 % -2. 34 % 5. 28 %
revenue growth:  84. 40 % 265. 25 % 73. 68 %
revenue/share:  0. 77   12. 72   60. 04  

beta (1yr vs S&P500):  1. 58   1. 27   0. 91  
sharpe (1yr):  -0. 85   0. 16   0. 77  

held % insiders:  17. 50 % 6. 06 % 3. 29 %
held % institutions:  77. 62 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : MCRB
.    101.434 =       101.434 :: --> INITIAL WEIGHT <--
.    - 2.335 =        99.099 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 1.988 =       196.996 :: P/E factor
.    x 2.209 =       435.156 :: PE/G factor
.    x 1.467 =       638.331 :: beta factor
.    x 0.946 =       603.969 :: sharpe factor
.    x 2.278 =      1375.709 :: current ratio factor
.    x 1.578 =      2171.142 :: quick ratio factor
.    x 1.111 =      2412.013 :: short ratio factor
.    x 2.083 =      5025.322 :: revenue growth factor
.    x 1.053 =      5292.186 :: EV/R factor
.    x 1.347 =       7128.32 :: debt-to-revenue factor
.                               --> PERFORMANCE <--
.    x 2.121 =     15117.692 :: sector+industry 1-year gains factor
.    x 1.009 =     15260.222 :: industry 12-weeks return factor
.    x 1.308 =     19958.671 :: industry 2-weeks return factor
.    x 0.987 =     19693.412 :: "drift" penalty 2 days ago
.    / 2.175 =       9055.27 :: overall "drift" factor
.    x 0.702 =      6352.568 :: largest single-day jump factor
.    x 0.071 =       451.177 :: low price factor
.    x 1.097 =       494.889 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.    x 0.905 =       447.701 :: forward EPS factor
.    x 0.965 =       432.189 :: forward P/E factor
.    x 1.185 =        512.02 :: industry recommendation factor
.    x 2.191 =      1122.073 :: company recommendation factor
.    x 1.003 =      1125.176 :: factor historical industry gain for week 29
.    x 9.615 =     10819.113 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        10.199 :: reduced for readability
.     + 4.77 =        14.969 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                     14.969 :: FINAL WEIGHT for NASDAQ:MCRB


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org